SUBSCRIBE
SUBSCRIBE

Kentucky

PRESS RELEASES
Press Releases
Bexion Pharmaceuticals, Inc. to Participate in the Jefferies London Healthcare Conference
November 12, 2024
 · 
2 min read
Press Releases
Onco360® Has Been Selected as a National Specialty Pharmacy Partner for Itovebi™ (inavolisib)
November 12, 2024
 · 
4 min read
Press Releases
Bexion Pharmaceuticals, Inc. Announces Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting
November 5, 2024
 · 
2 min read
Press Releases
Breath Diagnostics Inc. Appoints Aaron Roebuck as President and Closes Financing
November 1, 2024
 · 
4 min read
Press Releases
Bexion Pharmaceuticals, Inc. Announces Publication of Phase 1 Data for BXQ-350 in Advanced Solid Tumors
October 31, 2024
 · 
3 min read
Press Releases
Norton Healthcare acquires groundbreaking focused ultrasound technology
October 15, 2024
 · 
2 min read
Press Releases
Onco360® Has Been Selected as The National Specialty Pharmacy Partner for Tevimbra® (tislelizumab-jsgr)
October 4, 2024
 · 
3 min read
Press Releases
Eurofins Genomics US Expands Capabilities with New GMP Oligonucleotide Manufacturing Facility
September 20, 2024
 · 
2 min read
Press Releases
World-renowned diabetes researcher joins Wendy Novak Diabetes Institute
September 10, 2024
 · 
3 min read
Press Releases
Holland Foundation for Sight Restoration Announces Second Annual Ocular Surface Stem Cell Transplantation Education Conference
September 4, 2024
 · 
1 min read
Drug Development
LAZCLUZE™ (lazertinib) Now Available from Onco360 for the First-line Treatment, in Combination with Rybrevant®, of Adult Patients with Metastatic Non-Small Cell Lung Cancer Whose Tumors Have EGFR Exon 19 Deletions or Exon 21 L858R Mutations
August 30, 2024
 · 
3 min read
Press Releases
Neogen Announced as an Official Sponsor of US Equestrian
August 22, 2024
 · 
2 min read
Press Releases
Onco360® Has Been Selected as a National Specialty Pharmacy Partner for VORANIGO® (vorasidenib)
August 12, 2024
 · 
2 min read
Press Releases
Onco360® Has Been Selected as a National Specialty Pharmacy for crovalimab-akkz
August 5, 2024
 · 
4 min read
Press Releases
66 Confluent Health Physical and Occupational Therapists Receive Board-Certified Clinical Specialist Credential
July 30, 2024
 · 
5 min read
Press Releases
FDA Grants PharmassêtX Orphan Drug Designation for Treatment of Rare Form of Inflammatory Bowel Disease with Active Component from Green Tea
July 10, 2024
 · 
7 min read